) --

Bristol-Myers Squibb Company



) hit a new 52-week high Wednesday as it is currently trading at $29.74, above its previous 52-week high of $29.73 with 5.8 million shares traded as of 12:35 p.m. ET. Average volume has been 12.9 million shares over the past 30 days.

Bristol-Myers Squibb has a market cap of $50 billion and is part of the

health care

sector and


industry. Shares are up 10% year to date as of the close of trading on Tuesday.

TheStreet Recommends

Bristol-Myers Squibb Company, a global biopharmaceutical company, discovers, develops, and delivers innovative medicines that help patients prevail over serious diseases. The company has a P/E ratio of 15.2, below the average drugs industry P/E ratio of 15.3 and below the S&P 500 P/E ratio of 17.7.

  • Practice your BMY trading strategies and win cash in our stock game.

TheStreet Ratings rates Bristol-Myers Squibb as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

Bristol-Myers Squibb Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center